Janssen/Pharmacyclics gain FDA nod for Imbruvica
November 14, 2013Sales and Marketing FDA, Janssen, Pharmacyclics, Revlimid, Velcade
The FDA has approved Janssen and Pharmacyclics’ Imbruvica to treat patients with mantle cell lymphoma (MCL), a rare and aggressive …
EMA delays data transparency
November 14, 2013Medical Communications, Research and Development, Sales and Marketing EMA, FDA, all trials, transparency
The European Medicines Agency has delayed its much-trailed plan to launch a clear policy on making clinical trial data publically …
ISPE names vice president of Europe
November 14, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ISPE
The International Society for Pharmaceutical Engineering which is the world’s largest not-for-profit association, has appointed former Boehringer head Dr Thomas …
Dendreon slashes more jobs
November 13, 2013Manufacturing and Production, Research and Development, Sales and Marketing Cancer, Dendreon, Provenge, cuts
Another 150 jobs are to go at Dendreon Corporation as the company seeks to cut $125 million per year in …
GSK heart disease drug fails late-stage trial
November 13, 2013Sales and Marketing GSK, darapladib, heart, statin
GSK has said its investigational chronic coronary heart disease pill darapladib has failed to meet its primary endpoint in a …
New Policy manager for the ABPI
November 13, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, andrew
The ABPI has appointed Andrew Hollingsworth as its new Policy manager who will take up the position on 25 November. …
SMC approves Inlyta
November 13, 2013Sales and Marketing Pfizer, SMC, Sutent, inylta, rcc
Pfizer’s kidney cancer drug Inlyta has been approved by the drugs watchdog in Scotland, making it the only country in …
NHS Confederation hires new chief executive and deputy chair
November 12, 2013Sales and Marketing Mike Farrar, NHS, NHS Confederation, Rob webster, cash
The NHS Confederation has confirmed that Rob Webster is to succeed Mike Farrar as its new chief executive, as it …
Amgen commits $2.5 million to biotech educational grants
November 12, 2013Research and Development, Sales and Marketing Amgen, EDC, Onyx, biotech, stem
The Amgen Foundation has announced $2.5 million in new grants for its science programme to aid schools in the US …
Eisai signs tropical disease deal
November 12, 2013Research and Development, Sales and Marketing Disease, Eisai, Japan, broad, ntd, tropical
Eisai has become the latest pharma firm to partner with the US-based Broad Institute to pool expertise and come up …
Novartis takes top honours in ISPE facility competition
November 12, 2013Manufacturing and Production Novartis, WHO, foya, holly springs
Novartis’ cell culture facility in the US for the production of influenza vaccines has claimed the top prize in the …
NICE needs more Velcade data
November 12, 2013Sales and Marketing NHS, NICE, Velcade, eric low
NICE has slowed the progress of Janssen Cilag’s Velcade towards becoming an NHS treatment for multiple myeloma by asking the …
Celgene hires new medical director
November 12, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, kilcoyne
Biopharma firm Celgene has announced the appointment of Dr Adrian Kilcoyne as its new medical director. He will take up …
AstraZeneca ups cancer drug production at Alderley Park
November 11, 2013Manufacturing and Production, Sales and Marketing AstraZeneca, Cancer, Zoladex, alderley park
AstraZeneca says it plans to invest around £120 million in a new cancer drug manufacturing facility at its plant in …
Sanofi to produce weight-loss drug for Orexigen
November 11, 2013Manufacturing and Production, Sales and Marketing Contrave, FDA, Sanofi, orexigen
Sanofi has agreed a deal to manufacture Orexigen Therapeutics’ weight-loss candidate Contrave outside North America. Under the commercial supply agreement, …
Shire spends $4.2 billion on ViroPharma purchase
November 11, 2013Sales and Marketing Cinryze, Firazyr, Shire, Viropharma
Shire has announced a $4.2 billion deal to buy US-based ViroPharma in a pact that is designed to bolster the …
Cancer Research backs ‘unique’ database
November 11, 2013Research and Development, Sales and Marketing Cancer, Database, ICR, cansar
An oncology database – said to be the world’s largest in any disease area and funded by Cancer Research UK …
Novartis sheds blood diagnostics for $1.7 billion
November 11, 2013Sales and Marketing Genoptix, Novartis, blood, grifols
Novartis has announced the sale of its blood transfusion diagnostics unit to the specialist Spanish firm Grifols for $1.67 billion.Headquartered …
‘Fatal’ safety concerns throw doubt on Lemtrada
November 11, 2013Research and Development, Sales and Marketing FDA, Genzyme, Lemtrada, MS, Sanofi
An FDA committee has dashed hopes of an approval for Sanofi’s multiple sclerosis drug after saying its benefits may not …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
